MY112414A - Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals - Google Patents

Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals

Info

Publication number
MY112414A
MY112414A MYPI94002896A MYPI19942896A MY112414A MY 112414 A MY112414 A MY 112414A MY PI94002896 A MYPI94002896 A MY PI94002896A MY PI19942896 A MYPI19942896 A MY PI19942896A MY 112414 A MY112414 A MY 112414A
Authority
MY
Malaysia
Prior art keywords
pharmaceuticals
preparation
substituted heterocyclic
heterocyclic carboxamide
carboxamide esters
Prior art date
Application number
MYPI94002896A
Inventor
Klaus Wollmann Dr
Georg Tschank Dr
Martin Bickel Dr
Karl-Heinz Baringhaus Dr
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MY112414A publication Critical patent/MY112414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE INVENTION RELATES TO COMPOUNDS OF THE FORMULA I, FORMULA 1 TO A PROCESS FOR THEIR PREPARATION AND TO THEIR USE AS PHARMACEUTICALS. THE COMPOUNDS ARE EMPLOYED, IN PARTICULAR, AS ESTER PRODRUGS OF PROLYL HYDROXYLASE INHIBITORS FOR INHIBITING COLLAGEN BIOSYNTHESIS AND AS FIBRO-SUPPRESSIVE AGENTS.
MYPI94002896A 1993-11-02 1994-10-31 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals MY112414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4337270A DE4337270A1 (en) 1993-11-02 1993-11-02 Substituted heterocyclic carboxamidoesters, their preparation and their use as medicaments

Publications (1)

Publication Number Publication Date
MY112414A true MY112414A (en) 2001-06-30

Family

ID=6501545

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94002896A MY112414A (en) 1993-11-02 1994-10-31 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals

Country Status (3)

Country Link
DE (1) DE4337270A1 (en)
MY (1) MY112414A (en)
ZA (1) ZA948579B (en)

Also Published As

Publication number Publication date
ZA948579B (en) 1995-06-27
DE4337270A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
PH31264A (en) Substituted heterocyclic carboxamide esters, and their use as pharmaceuticals.
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
RU94045141A (en) Heterocyclic derivatives of carboxylic acid and their salts and pharmaceutical composition showing antifibrotic or prolylhydroxylase-inhibiting activity or collagen biosynthesis inhibition
HUP9900816A3 (en) Use of piperidine carboxylic acid derivatives for producing pharmaceutical compositions as inhibitors of rotamase enzyme activity
EP0693083A4 (en) Alpha-ketoamide derivatives as inhibitors of thrombosis
AU4041293A (en) Phenylderivate as inhibitors of atp citrate lyase
TW225534B (en)
HUP9901752A3 (en) Piperidine carboxylic acid derivatives as rotamase enzyme activity inhibitors and use of them for producing pharmaceutical compositions suitable for treating neurological activity
DE69711391D1 (en) IMPROVED METHOD FOR PRODUCING PROTECTED 3,4-DIHYDROXYBUTTERIC ACID ESTERS
PL318595A1 (en) Derivatives of phenyloacetic acid, method of and intermediate products for obtaining them and agents containing such derivatives
AU6570186A (en) Novel pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity and synthesis and use thereof
AU9066498A (en) Substituted 6-alkylphenanthridines
EP0658585A3 (en) Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants.
MY104354A (en) Non-peptidic renin inhibitors
MY112414A (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
CA2208032A1 (en) Substituted amidinonaphthyl ester derivative
NZ334404A (en) L-trans-2-amino-4-(acetamidoethoxy)-3-butenoic acid also known as N-acetyl aminoethoxyvinylglycine and its use as an ethylene biosynthesis inhibitor